And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is relatively modest. We hope to catch up on some reading, hang with a short person or two, take some long strolls with Mrs. Pharmalot, and catch another installment of our “Let’s-see-them-before-they-die” concert series. And what about you? This is a lovely time of year to enjoy the great outdoors. You could putter around your castle and tidy up. Perhaps this is an opportunity to make time for someone special. Or you could answer the help wanted sign at the Federal Reserve; we understand a certain someone in Washington is having trouble finding a good candidate. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Medicare spending would climb by $187 billion and Medicaid by $7 billion over the next decade if the Center for Medicare and Medicaid Services finalizes a rule to repeal the safe harbor for Part D rebates, Modern Healthcare writes, citing an analysis by the Congressional Budget Office. The Trump administration proposed replacing the safe harbor for rebates from prosecution under the anti-kickback statute with a new one for discounts at the point of sale, by January 2020.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy